ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

ClinicalTrials.gov ID: NCT04378569

Public ClinicalTrials.gov record NCT04378569. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2b, Multiple Dose and 12-Week, Parallel Group, Double Blind, Dose Ranging, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-252 Cream 0.1% and ARQ-252 Cream 0.3% in Subjects With Chronic Hand Eczema

Study identification

NCT ID
NCT04378569
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Arcutis Biotherapeutics, Inc.
Industry
Enrollment
230 participants

Conditions and interventions

Interventions

  • ARQ-252 Vehicle Cream Drug
  • ARQ-252 cream 0.1% Drug
  • ARQ-252 cream 0.3% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 19, 2020
Primary completion
Feb 23, 2021
Completion
Feb 23, 2021
Last update posted
Apr 4, 2024

2020 – 2021

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
Arcutis Clinical Site 239 Beverly Hills California 90212
Arcutis Clinical Site 225 Encino California 91436
Arcutis Clinical Site 112 Fremont California 94538
Arcutis Clinical Site 120 Irvine California 92797
Arcutis Clinical Site 208 Santa Monica California 90404
Arcutis Clinical Site 174 Aventura Florida 33180
Arcutis Clinical Site 167 Coral Gables Florida 33134
Arcutis Clinical Site 104 Sanford Florida 32771
Arcutis Clinical Site 214 Indianapolis Indiana 46250
Arcutis Clinical Site 217 Louisville Kentucky 40217
Arcutis Clinical Site 213 Metairie Louisiana 70006
Arcutis Clinical Site 125 Rockville Maryland 20850
Arcutis Clinical Site 212 Detroit Michigan 48202
Arcutis Clinical Site 216 New Brighton Minnesota 55112
Arcutis Clinical Site 171 New York New York 10029
Arcutis Clinical Site 115 High Point North Carolina 27262
Arcutis Clinical Site 173 Portland Oregon 97210
Arcutis Clinical Site 135 Pittsburgh Pennsylvania 15213
Arcutis Clinical Site 162 Austin Texas 78759
Arcutis Clinical Site 104 College Station Texas 77845
Arcutis Clinical Site 164 Houston Texas 77056
Arcutis Clinical Site 163 Pflugerville Texas 78660
Arcutis Clinical Site 161 San Antonio Texas 78213
Arcutis Clinical Site 110 San Antonio Texas 78218
Arcutis Clinical Site 169 Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04378569, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2024 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04378569 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →